Facebook Icon Print Created with Sketch. Twitter Icon Created with Sketch. Created with Sketch. LinkedIn Icon Green Check Icon Created with Sketch. YouTube Icon Right Arrow Icon Mobile Menu Icon Chevron Right Icon Phone Icon Health Study Area: AutoImmune Disease Health Study Area: Blood Cancer Health Study Area: Cardiovascular Disease Health Study Area: Fibrosis Health Study Area: Gastrointestinal Cancer Health Study Area: Genitourinary Health Study Area: Head and Neck Cancer Health Study Area: Lung Cancer Health Study Area: Melanoma For Caregivers For Clinicians Communities FAQs For Parents For Patients Chevron Icon Bookmark Icon Map Icon Share Icon Direction Arrow Icon Direction Arrow Icon Page Icon Location Icon Search Icon External Link Icon Help Icon Error Icon Glossary Email Icon Gender Both Gender Male Gender Female Created with Sketch. Created with Sketch.

Please Log In/Join Now first, and then use this function!

About Study
Connect

At Bristol-Myers Squibb, our mission is to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases.

What we offer

Study Connect is starting point for patients considering taking part in our clinical trials. It’s also a place for patients, their caregivers, and physicians to learn more about how clinical trials work and how they might be part of making sure new medicines are effective and safe. Whether it’s your first clinical trial or if you’ve been through one before, Study Connect is here to help you find a trial that may be right for you.

The Bristol-Myers Squibb Commitment

Just as the field of medicine changes almost day-to-day, we’re constantly working to improve how we work. Our aspiration is that patients and researchers will quickly experience the impact of our changes.

  • 150+

    CLINICAL TRIALS

  • 50+

    COUNTRIES

  • 50k+

    PARTICIPANTS

Numbers above represent world-wide figures.

Let Us Guide You

Help Center

Visit our help center for FAQs

Read more

Need Support?

Organizations that support patients

Read more

Have questions? Email Us

Have questions?
Email Us